423 related articles for article (PubMed ID: 34333735)
1. LncRNA as a multifunctional regulator in cancer multi-drug resistance.
He J; Zhu S; Liang X; Zhang Q; Luo X; Liu C; Song L
Mol Biol Rep; 2021 Aug; 48(8):1-15. PubMed ID: 34333735
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
3. The role of long non-coding RNAs in drug resistance of cancer.
Zhang HD; Jiang LH; Zhong SL; Li J; Sun DW; Hou JC; Wang DD; Zhou SY; Tang JH
Clin Genet; 2021 Jan; 99(1):84-92. PubMed ID: 32583420
[TBL] [Abstract][Full Text] [Related]
4. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
Zhang X; Yang H
Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
Abu N; Hon KW; Jeyaraman S; Jamal R
Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
[TBL] [Abstract][Full Text] [Related]
6. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of long non-coding RNAs as diagnostic markers for lung cancer and other malignant tumors.
Li L; Wei H; Zhang YW; Zhao S; Che G; Wang Y; Chen L
Aging (Albany NY); 2021 Oct; 13(20):23842-23867. PubMed ID: 34670194
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
Singh D; Khan MA; Siddique HR
Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNAs in anti-cancer drug resistance.
Chen QN; Wei CC; Wang ZX; Sun M
Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
[TBL] [Abstract][Full Text] [Related]
10. SNHG11: A New Budding Star in Tumors and Inflammatory Diseases.
Wu Y
Mini Rev Med Chem; 2023; 23(20):1993-2006. PubMed ID: 37165588
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNAs regulate drug resistance in cancer.
Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Fang L; Wang H; Li P
Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
[TBL] [Abstract][Full Text] [Related]
15. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer.
Wu Y; Yang X; Xie Z; Hu H; Lei X; Niu D; Li S; Tuo L
Comb Chem High Throughput Screen; 2022; 25(13):2127-2140. PubMed ID: 35366768
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review of the role of lncRNAs in gastric cancer (GC) pathogenesis, immune regulation, and their clinical applications.
Siri G; Yazdani O; Esbati R; Akhavanfar R; Asadi F; Adili A; Ebrahimzadeh F; Hosseini SME
Pathol Res Pract; 2023 Jan; 241():154221. PubMed ID: 36563559
[TBL] [Abstract][Full Text] [Related]
17. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer.
Li D; Weng S; Zeng K; Xu H; Wang W; Shi J; Chen J; Chen C
Gene; 2024 Feb; 895():148007. PubMed ID: 37981080
[TBL] [Abstract][Full Text] [Related]
19. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
[TBL] [Abstract][Full Text] [Related]
20. Gene expression regulations by long noncoding RNAs and their roles in cancer.
Du XH; Wei H; Qu GX; Tian ZC; Yao WT; Cai QQ
Pathol Res Pract; 2020 Jun; 216(6):152983. PubMed ID: 32327283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
